Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 54.67 · gapped above the open, then crossed back over prior close. High/low 55.47 at 9:30 am ET, 53.98 at 11:15 am ET.
Anaptysbio, Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We currently recognize revenue from milestones and royalties achieved under our immuno-oncology collaboration with GSK and license and transition services revenue from our collaboration with Vanda.”
FILING10-K0001193125-26-088290cik 0001370053
“We currently recognize revenue from milestones and royalties achieved under our immuno-oncology collaboration with GSK and license and transition services revenue from our collaboration with Vanda.”
FILING10-K0001193125-26-088290cik 0001370053
“In September 2022, we signed a royalty monetization agreement (the "Zejula Royalty Monetization Agreement") with a wholly owned subsidiary of DRI Healthcare Trust ("DRI") to monetize all of our future royalties on global net sales of Zejula under the GSK Settlement Agreement.”
FILING10-K0001193125-26-088290cik 0001370053
“In October 2021, we signed a royalty monetization agreement ("Jemperli Royalty Monetization Agreement") with Sagard Healthcare Royalty Partners, LP ("Sagard").”
FILING10-K0001193125-26-088290cik 0001370053
“In November 2024, we entered into an open market sales agreement with TD Securities (USA) LLC ("TD Cowen"), under which we may offer and sell shares of our common stock up to, an aggregate offering of $100.0 million through TD Cowen as our sales agent.”
FILING10-K0001193125-26-088290cik 0001370053
Watchlist prices, news filtered to it, and its next report on your desk.
Anaptysbio, Inc has 3 disclosed suppliers and 2 disclosed customers. Each one is named in an SEC filing, either Anaptysbio, Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
ANAB (Anaptysbio, Inc) has 3 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: VNDA −3.38%, in healthcare.